|
|
|
Insider
Information: |
Sinha Vikas |
Relationship: |
|
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
1,308,459 |
|
Indirect Shares
|
16,674,766 |
|
|
Direct
Value |
$33,429,650 |
|
|
Indirect Value
|
$12,692,832 |
|
|
Total
Shares |
17,983,225 |
|
|
Total
Value |
$46,122,482 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
23
|
Stock
price went up :
|
0
|
6
|
Stock
price went down : |
0
|
17
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-743.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
25,974 |
134,321 |
0 |
- |
|
ALVR |
Allovir Inc |
See RemarksOfficer |
|
2020-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
806,607 |
|
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
|
2008-08-01 |
4 |
OE |
$27.58 |
$275,800 |
D/D |
10,000 |
41,149 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-02-22 |
4 |
OE |
$13.79 |
$413,700 |
D/D |
30,000 |
84,307 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-03-25 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
74,307 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-09-15 |
4 |
OE |
$16.35 |
$196,200 |
D/D |
12,000 |
65,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-09-28 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
85,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-09-29 |
4 |
OE |
$16.35 |
$65,400 |
D/D |
4,000 |
69,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-11-03 |
4 |
OE |
$13.79 |
$341,200 |
D/D |
24,000 |
73,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-11-19 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
93,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2010-11-22 |
4 |
OE |
$16.35 |
$65,400 |
D/D |
4,000 |
77,281 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-02-14 |
4 |
OE |
$13.79 |
$378,741 |
D/D |
25,002 |
106,480 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-04-01 |
4 |
OE |
$13.79 |
$137,900 |
D/D |
10,000 |
96,480 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-07-13 |
4 |
OE |
$6.90 |
$100,505 |
D/D |
14,566 |
367,540 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2011-07-25 |
4 |
OE |
$5.18 |
$141,095 |
D/D |
25,434 |
378,408 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2012-01-09 |
4 |
OE |
$5.18 |
$203,570 |
D/D |
25,664 |
377,767 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2012-03-20 |
4 |
OE |
$10.29 |
$226,339 |
D/D |
21,996 |
385,384 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
|
2012-07-27 |
4 |
OE |
$11.92 |
$357,600 |
D/D |
30,000 |
345,388 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-07-12 |
4 |
OE |
$11.92 |
$667,648 |
D/D |
50,000 |
362,655 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-10-28 |
4 |
OE |
$17.65 |
$882,500 |
D/D |
50,000 |
360,808 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-12-09 |
4 |
OE |
$17.65 |
$317,241 |
D/D |
17,974 |
152,295 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2013-12-18 |
4 |
OE |
$17.65 |
$565,259 |
D/D |
32,026 |
166,347 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-10-31 |
4 |
OE |
$17.65 |
$346,186 |
D/D |
19,307 |
182,077 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-11-03 |
4 |
OE |
$17.96 |
$538,800 |
D/D |
30,000 |
192,770 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
|
2014-11-06 |
4 |
OE |
$17.98 |
$102,360 |
D/D |
5,693 |
168,463 |
0 |
- |
|
145 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|